Scroll Top

Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

MedPage Today) — In acute coronary syndrome (ACS), a prasugrel (Effient)-based antiplatelet regimen passed muster for reducing bleeding without compromising ischemic protection after percutaneous coronary intervention (PCI).
4D-ACS trial investigators…
Read More

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.